Cannabidiol (CBD)

DRUG20 trials

Conditions

Alcohol Use Disorder (AUD)ArthralgiaAtopic DermatitisBreast CancerCancerCannabis UseChronic PruritusClinical High Risk for Developing Psychosis

Early Phase 1

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

RecruitingNCT07167446

Fox Chase Cancer CenterMetastatic Colorectal Cancer (CRC), Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients, Peripheral Neuropathy Due to Chemotherapy

Start: 2025-10-14End: 2028-09-07Target: 30Updated: 2025-10-22

Phase 1

Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

CompletedNCT04193631

Pure GreenMusculoskeletal Pain

Start: 2019-12-07End: 2019-12-09Updated: 2020-03-24

A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain

Not yet recruitingNCT06695195

Brent DeGeorgeUpper Extremity Bone Pain, Upper Extremity Muscle Pain, Upper Extremity Pain

Start: 2025-06-30End: 2026-03-31Target: 100Updated: 2025-04-09

Phase 2

A Study: Pure CBD as Single-agent for Solid Tumor.

NCT02255292

Hadassah Medical OrganizationSolid Tumor

Start: 2014-11-30End: 2015-07-31Target: 60Updated: 2014-10-02

Effects of Cannabidiol on Psychiatric Symptoms, Cognition, and Cannabis Consumption in Cannabis Users With Recent-Onset Psychosis

WithdrawnNCT03883360

University of Maryland, BaltimoreCannabis Use, Schizophrenia Spectrum Disorders

Start: 2050-01-31End: 2050-03-31Updated: 2021-04-19

Neuroimaging and CBD for Opioid Use Disorder

CompletedNCT04567784

Yasmin HurdHeroin Abuse, Opioid-Related Disorders, Opioid Use Disorder +1

Start: 2020-11-12End: 2025-06-18Updated: 2025-10-27

Cannabidiol (CBD) for Treatment of Aromatase Inhibitor-Associated Arthralgias

CompletedNCT04754399

University of Michigan Rogel Cancer CenterArthralgia, Breast Cancer

Start: 2021-04-16End: 2023-10-10Updated: 2025-05-09

Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee

RecruitingNCT04992624

Steven E Harte, PhDOsteoarthritis, Knee, Osteoarthritis of the Knee

Start: 2022-02-22End: 2027-06-30Target: 200Updated: 2026-09-04

Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

RecruitingNCT05020028

NYU Langone HealthKnee Arthritis

Start: 2022-06-22End: 2027-09-01Target: 100Updated: 2026-06-09

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

RecruitingNCT05269628

Tiffany J. Braley, MD, MSMultiple Sclerosis, Pain, Sleep

Start: 2022-03-25End: 2027-08-30Target: 166Updated: 2026-07-17

The Efficacy and Neurobehavioural Mechanism of Cannabidiol (CBD) for Alcohol Dependence

NCT05387148

South West Sydney Local Health DistrictAlcohol Use Disorder (AUD)

Start: 2022-06-30End: 2024-06-30Target: 20Updated: 2022-06-03

A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients

TerminatedNCT05753007

Mclean HospitalGlioblastoma

Start: 2024-02-15End: 2025-02-11Updated: 2026-03-16

Efficacy of Topical Cannabidiol for Eczema

Enrolling by invitationNCT06994520

Khon Kaen UniversityAtopic Dermatitis, Chronic Pruritus, Eczema +2

Start: 2025-05-01End: 2027-12-31Target: 60Updated: 2026-08-04

Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving

Not yet recruitingNCT07148843

Johns Hopkins UniversityAlcohol Use Disorder (AUD), Craving, Withdrawal From Addictive Substance; Detoxification

Start: 2026-10-01End: 2030-10-31Target: 105Updated: 2026-08-18

CBD Knee Osteoarthritis Study

Not yet recruitingNCT07638189

University of TennesseeOsteoarthitis

Start: 2026-07-01End: 2028-03-30Target: 30Updated: 2026-06-10

Phase 3

Stratification and Treatment in Early Psychosis Study - PROMOTE

Not yet recruitingNCT07434973

University of OxfordClinical High Risk for Developing Psychosis, Clinical High Risk for Psychosis, Clinical High Risk for Psychosis (CHR)

Start: 2026-05-01End: 2031-12-01Target: 586Updated: 2026-02-27

Unknown Phase

Cannabidiol for Pediatric Epilepsy (Compassionate Use)

NCT02556008

University of California, Los AngelesRefractory Childhood Epilepsy

Updated: 2026-01-22

CBD, Immune Function, and Neural Health

CompletedNCT04881539

University of Northern ColoradoHealthy

Start: 2021-05-15End: 2022-03-18Updated: 2022-03-31

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

Active, not recruitingNCT05836857

M.D. Anderson Cancer CenterCancer

Start: 2023-01-30End: 2027-05-31Target: 100Updated: 2026-04-16

Study of Cannabidiol (CBD) in Healthy Volunteers

CompletedNCT06286839

NextEvo Inc.Immune System and Related Disorders, Immune System Diseases

Start: 2022-05-12End: 2022-12-14Updated: 2024-02-29

Related Papers

Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor‐Associated Musculoskeletal Symptoms in Breast Cancer

Cancer Medicine2025-08-012 citations

The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial.

2024-08-135 citations

The impact of cannabidiol (CBD) on aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS).

Journal of Clinical Oncology2024-06-013 citations

Abstract PO1-11-06: Evaluating Symptom Clusters in Patients with Breast Cancer Experiencing Aromatase Inhibitor-Associated Musculoskeletal Symptoms

Cancer Research2024-05-02